Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Nakamura MM"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study.
Autorzy:
Sherman G; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School.
Lamb GS; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School.
Sharma TS; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School.
Lloyd EC; Department of Pediatrics, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Nagel J; Department of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Dandam NN; Department of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Oliveira CR; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Sheikha HS; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Anosike BI; Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Lee P; Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Vora SB; Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
Patel K; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Sue PK; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Rubbab B; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Yarbrough AM; Department of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA.
Ganapathi L; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School.
Nakamura MM; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, MA, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2023 Apr 18; Vol. 12 (3), pp. 152-155.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
COVID-19*
Humans ; Child ; Retrospective Studies ; Antibodies, Monoclonal/therapeutic use ; Hospitalization ; Hospitals, Pediatric
Czasopismo naukowe
Tytuł:
Community-Onset Bacterial Coinfection in Children Critically Ill With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Autorzy:
Moffitt KL; Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Nakamura MM; Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Young CC; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Newhams MM; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Halasa NB; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Reed JN; Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.
Fitzgerald JC; Division of Critical Care, Department of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Spinella PC; Division of Critical Care, Department of Pediatrics, Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
Soma VL; Division of Pediatric Infectious Diseases, Department of Pediatrics, New York University Grossman School of Medicine, Hassenfeld Children's Hospital, New York, New York, USA.
Walker TC; Department of Pediatrics, University of North Carolina at Chapel Hill Children's Hospital, Chapel Hill, North Carolina, USA.
Loftis LL; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Maddux AB; Department of Pediatrics, Section of Critical Care Medicine, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Kong M; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Rowan CM; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana, USA.
Hobbs CV; Department of Pediatrics, Division of Disease, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Schuster JE; Division of Pediatric Infectious Disease, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.
Riggs BJ; Division of Pediatric Anesthesiology and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
McLaughlin GE; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA.
Michelson KN; Division of Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Hall MW; Division of Critical Care Medicine, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA.
Babbitt CJ; Miller Children's and Women's Hospital of Long Beach, Long Beach, California, USA.
Cvijanovich NZ; Division of Critical Care Medicine, University of California, San Francisco Benioff Children's Hospital, Oakland, California, USA.
Zinter MS; School of Medicine, Department of Pediatrics, Division of Critical Care Medicine, University of California, San Francisco, San Francisco, California, USA.
Maamari M; Department of Pediatrics, Division of Critical Care Medicine, University of Texas Southwestern, Children's Health Medical Center Dallas, Dallas, Texas, USA.
Schwarz AJ; Division of Critical Care Medicine, Children's Hospital Orange County, Orange, California, USA.
Singh AR; Pediatric Critical Care Division, Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College, Valhalla, New York, USA.
Flori HR; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan, USA.
Gertz SJ; Division of Pediatric Critical Care, Department of Pediatrics, Cooperman Barnabas Medical Center, Livingston, New Jersey, USA.
Staat MA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Giuliano JS Jr; Department of Pediatrics, Division of Critical Care, Yale University School of Medicine, New Haven, Connecticut, USA.
Hymes SR; Division of Pediatric Infectious Diseases, Stony Brook Children's Hospital, Renaissance School of Medicine, Stony Brook, New York, USA.
Clouser KN; Department of Pediatrics, Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA.
McGuire J; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Seattle Children's Hospital and the University of Washington, Seattle, Washington, USA.
Carroll CL; Division of Critical Care, Connecticut Children's, Hartford, Connecticut, USA.
Thomas NJ; Department of Pediatrics, Penn State Hershey Children's Hospital, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Levy ER; Divisions of Pediatric Infectious Diseases and Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Randolph AG; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Mar 06; Vol. 10 (3), pp. ofad122. Date of Electronic Publication: 2023 Mar 06 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Epidemiology and Management of Orbital Cellulitis in Children.
Autorzy:
Anosike BI; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Ganapathy V; Medical College of Georgia, Augusta, Georgia, USA.
Nakamura MM; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2022 May 30; Vol. 11 (5), pp. 214-220.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Methicillin-Resistant Staphylococcus aureus*
Orbital Cellulitis*/drug therapy
Orbital Cellulitis*/epidemiology
Staphylococcal Infections*/diagnosis
Staphylococcal Infections*/drug therapy
Staphylococcal Infections*/epidemiology
Abscess/drug therapy ; Adrenal Cortex Hormones/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Child ; Humans ; Infant, Newborn ; Retrospective Studies ; Staphylococcus aureus ; Vancomycin/therapeutic use
Czasopismo naukowe
Tytuł:
Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents.
Autorzy:
Wolf J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Abzug MJ; Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Anosike BI; Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Vora SB; Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
Waghmare A; Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
Sue PK; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Olivero RM; Department of Pediatrics and Human Development, Helen DeVos Children's Hospital of Spectrum Health, Michigan State College of Human Medicine, Grand Rapids, Michigan, USA.
Oliveira CR; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
James SH; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Morton TH; Department of Pharmacy, St Jude's Children's Research Hospital, Memphis, Tennessee, USA.
Maron GM; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Young JL; Department of Pharmacy, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Orscheln RC; Department of Pediatrics, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Schwenk HT; Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Bio LL; Department of Pharmacy, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Willis ZI; Department of Pediatrics, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Lloyd EC; Department of Pediatrics, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Hersh AL; Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Huskins CW; Department of Pediatrics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Soma VL; Department of Pediatrics, Hassenfeld Children's Hospital, NYU Grossman School of Medicine, New York, New York, USA.
Ratner AJ; Department of Pediatrics, Hassenfeld Children's Hospital, NYU Grossman School of Medicine, New York, New York, USA.
Hayes M; Center for Healthcare Quality & Analytics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Downes K; Department of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Chiotos K; Department of Anesthesia and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Grapentine SP; Department of Pharmacy, University of California-San Francisco, San Francisco, California, USA.
Wattier RL; Department of Pediatrics, University of California-San Francisco, San Francisco, California, USA.
Lamb GS; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Zachariah P; Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
Nakamura MM; Antimicrobial Stewardship Program and Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2022 May 30; Vol. 11 (5), pp. 177-185.
Typ publikacji:
Journal Article
MeSH Terms:
Practice Guidelines as Topic*
COVID-19 Drug Treatment*
Adolescent ; Adult ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antibodies, Neutralizing ; Antibodies, Viral ; Child ; Drug Combinations ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents.
Autorzy:
Wolf J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Abzug MJ; Department of Pediatrics, Division of Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Wattier RL; Department of Pediatrics, Division of Infectious Diseases and Global Health, University of California-San Francisco, San Francisco, California, USA.
Sue PK; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vora SB; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle.; Children's Hospital, Seattle, Washington, USA.
Zachariah P; Department of Pediatrics, Division of Infectious Diseases, Columbia University, New York, New York, USA.
Dulek DE; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Waghmare A; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle.; Children's Hospital, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA.
Olivero R; Section of Infectious Diseases, Department of Pediatrics and Human Development, Helen DeVos Children's Hospital of Spectrum Health, Michigan State College of Human Medicine, Grand Rapids, Michigan, USA.
Downes KJ; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
James SH; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pinninti SG; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Yarbrough A; Department of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA.
Aldrich ML; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital at Montefiore, New York, New York, USA.
MacBrayne CE; Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.
Soma VL; Department of Pediatrics, Division of Infectious Diseases, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.
Grapentine SP; Department of Pharmacy, University of California-San Francisco Benioff Children's Hospital, San Francisco, California, USA.
Oliveira CR; Department of Pediatrics, Division of Infectious Diseases and Global Health, Yale University School of Medicine, New Haven, Connecticut, USA.
Hayes M; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kimberlin DW; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jones SB; Department of Pharmacy, Boston Children's Hospital, Boston, Massachusetts, USA.
Bio LL; Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, California, USA.
Morton TH; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Hankins JS; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Maron GM; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Timberlake K; Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.
Young JL; Department of Pharmacy, St. Louis Children's Hospital, St. Louis, Missouri, USA.
Orscheln RC; Department of Pediatrics, Division of Infectious Diseases, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Schwenk HT; Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Goldman DL; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital at Montefiore, New York, New York, USA.
Groves HE; Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Ontario, Canada.
Huskins WC; Department of Pediatric and Adolescent Medicine, Division of Pediatric Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Rajapakse NS; Department of Pediatric and Adolescent Medicine, Division of Pediatric Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Lamb GS; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Tribble AC; Department of Pediatrics, Division of Infectious Diseases, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Lloyd EC; Department of Pediatrics, Division of Infectious Diseases, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Hersh AL; Department of Pediatrics, Division of Infectious Diseases, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Thorell EA; Department of Pediatrics, Division of Infectious Diseases, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Ratner AJ; Department of Pediatrics, Division of Infectious Diseases, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.; Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Chiotos K; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Anesthesia and Critical Care Medicine, Division of Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Nakamura MM; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 May 28; Vol. 10 (5), pp. 629-634.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Drug Treatment*
Antibodies, Monoclonal/*therapeutic use
Antiviral Agents/*therapeutic use
Pneumonia, Viral/*drug therapy
Adolescent ; Antibodies, Monoclonal, Humanized ; COVID-19/epidemiology ; Child ; Drug Approval ; Female ; Humans ; Male ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; United States/epidemiology ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł:
Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals.
Autorzy:
Ferguson RA; Department of Pediatrics, Washington University in St Louis, St Louis, Missouri, USA.
Herigon JC; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Lee BR; Health Services and Outcomes Research, Children's Mercy Kansas City, Kansas City, Missouri, USA.
Nakamura MM; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Newland JG; Department of Pediatrics, Washington University in St Louis, St Louis, Missouri, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 May 28; Vol. 10 (5), pp. 677-681.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Infections*/drug therapy
Ceftriaxone*/administration & dosage
Anti-Bacterial Agents/administration & dosage ; Child ; Child, Hospitalized ; Hospitals ; Humans ; United States
Czasopismo naukowe
Tytuł:
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Autorzy:
Chiotos K; Division of Critical Care Medicine, Department of Anesthesia and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hayes M; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kimberlin DW; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jones SB; Department of Pharmacy, Boston Children's Hospital, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
James SH; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pinninti SG; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Yarbrough A; Department of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA.
Abzug MJ; Division of Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
MacBrayne CE; Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.
Soma VL; Division of Infectious Diseases, Department of Pediatrics, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.
Dulek DE; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Vora SB; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.
Waghmare A; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Wolf J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Olivero R; Section of Infectious Diseases, Department of Pediatrics and Human Development, Helen DeVos Children's Hospital of Spectrum Health, Michigan State College of Human Medicine, Grand Rapids, Michigan, USA.
Grapentine S; Department of Pharmacy, University of California-San Francisco Benioff Children's Hospital, San Francisco, California, USA.
Wattier RL; Division of Infectious Diseases and Global Health, Department of Pediatrics, University of California-San Francisco, San Francisco, California, USA.
Bio L; Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, California, USA.
Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Dillman NO; Department of Pharmacy, CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Downes KJ; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Oliveira CR; Yale University School of Medicine, Yale University, New Haven, Connecticut, USA.
Timberlake K; Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.
Young J; Department of Pharmacy, St. Louis Children's Hospital, St. Louis, Missouri, USA.
Orscheln RC; Division of Infectious Diseases, Department of Pediatrics, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Tamma PD; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Schwenk HT; Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Zachariah P; Division of Infectious Diseases, Department of Pediatrics, Columbia University, New York, New York, USA.
Aldrich ML; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Goldman DL; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Groves HE; Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Rajapakse NS; Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Lamb GS; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Tribble AC; Department of Pediatrics, Division of Infectious Diseases, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Hersh AL; Division of Infectious Diseases, Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Thorell EA; Division of Infectious Diseases, Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Denison MR; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Ratner AJ; Division of Infectious Diseases, Department of Pediatrics, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.; Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Newland JG; Division of Infectious Diseases, Department of Pediatrics, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Nakamura MM; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 Feb 13; Vol. 10 (1), pp. 34-48.
Typ publikacji:
Consensus Development Conference; Journal Article
MeSH Terms:
COVID-19 Drug Treatment*
Antiviral Agents/*therapeutic use
Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; COVID-19/therapy ; Child ; Evidence-Based Medicine ; Humans ; Immunocompromised Host ; Risk Factors ; Severity of Illness Index ; Systemic Inflammatory Response Syndrome/drug therapy
SCR Disease Name:
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł:
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Autorzy:
Chiotos K; Department of Anesthesia and Critical Care Medicine, Division of Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hayes M; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kimberlin DW; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jones SB; Department of Pharmacy, Boston Children's Hospital, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
James SH; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pinninti SG; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Yarbrough A; Department of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA.
Abzug MJ; Department of Pediatrics, Division of Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
MacBrayne CE; Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.
Soma VL; Department of Pediatrics, Division of Infectious Diseases, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.
Dulek DE; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Vora SB; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.
Waghmare A; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Wolf J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Olivero R; Department of Pediatrics and Human Development, Section of Infectious Diseases, Helen DeVos Children's Hospital of Spectrum Health, Michigan State College of Human Medicine, Grand Rapids, Michigan, USA.
Grapentine S; Department of Pharmacy, University of California-San Francisco Benioff Children's Hospital, San Francisco, California, USA.
Wattier RL; Department of Pediatrics, Division of Infectious Diseases and Global Health, University of California-San Francisco, San Francisco, California, USA.
Bio L; Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Dillman NO; Department of Pharmacy, CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Downes KJ; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Timberlake K; Department of Pharmacy, The Hospital for Sick Children, Toronto, Canada.
Young J; Department of Pharmacy, St. Louis Children's Hospital, St. Louis, Missouri, USA.
Orscheln RC; Department of Pediatrics, Division of Infectious Diseases, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Tamma PD; Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Schwenk HT; Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Zachariah P; Department of Pediatrics, Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
Aldrich M; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital at Montefiore, New York, New York, USA.
Goldman DL; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital at Montefiore, New York, New York, USA.
Groves HE; Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada.
Lamb GS; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Tribble AC; Department of Pediatrics, Division of Infectious Diseases, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Hersh AL; Department of Pediatrics, Division of Infectious Diseases, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Thorell EA; Department of Pediatrics, Division of Infectious Diseases, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Denison MR; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Ratner AJ; Department of Pediatrics, Division of Infectious Diseases, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.; Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Newland JG; Department of Pediatrics, Division of Infectious Diseases, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Nakamura MM; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2020 Dec 31; Vol. 9 (6), pp. 701-715.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
COVID-19 Drug Treatment*
Antiviral Agents/*therapeutic use
Child ; Humans ; Risk Assessment ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Safety and Tolerability of Moxifloxacin in Children.
Autorzy:
Dixit A; Division of Infectious Diseases, Boston Children's Hospital, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Karandikar MV; Division of Infectious Diseases, Boston Children's Hospital, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Jones S; Division of Infectious Diseases, Boston Children's Hospital, Massachusetts.; Department of Pharmacy, Boston Children's Hospital, Massachusetts.
Nakamura MM; Division of Infectious Diseases, Boston Children's Hospital, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of General Pediatrics, Boston Children's Hospital, Massachusetts.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2018 Aug 17; Vol. 7 (3), pp. e92-e101.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Anti-Bacterial Agents/*adverse effects
Anti-Bacterial Agents/*therapeutic use
Bacterial Infections/*drug therapy
Fluoroquinolones/*adverse effects
Fluoroquinolones/*therapeutic use
Administration, Intravenous ; Administration, Oral ; Adolescent ; Alanine Transaminase/blood ; Alanine Transaminase/drug effects ; Aspartate Aminotransferases/blood ; Aspartate Aminotransferases/drug effects ; Bacterial Infections/blood ; Bacterial Infections/enzymology ; Bilirubin/blood ; Blood Cell Count ; Child ; Child, Preschool ; Drug Administration Schedule ; Female ; Humans ; Infant ; Long QT Syndrome/chemically induced ; Male ; Moxifloxacin ; Neutropenia/chemically induced ; Retrospective Studies ; Seizures/chemically induced
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies